News Releases

John D. Haynes School of Welding Technology Fills Critical Training Need to Support National Defense Priorities MOUNT VERNON, Ind. --(BUSINESS WIRE)--Oct. 24, 2024-- BWX Technologies, Inc. (NYSE: BWXT) today announced the opening of the John D. Haynes School of Welding Technology at Mount Vernon

LYNCHBURG, Va. --(BUSINESS WIRE)--Oct. 17, 2024-- BWX Technologies, Inc. (NYSE: BWXT) is pleased to announce that Hanford Tank Waste Operations & Closure, LLC (H2C) has been approved by the U.S. Department of Energy (DOE) to begin the Hanford Integrated Tank Disposition Contract (ITDC).

LYNCHBURG, Va. --(BUSINESS WIRE)--Oct. 8, 2024-- BWX Technologies, Inc. (NYSE: BWXT) today announced that its Nuclear Fuel Services, Inc. (NFS) subsidiary was selected by the U.S. Department of Energy (DOE) as one of the successful bidders for High-Assay Low-Enriched Uranium (HALEU) deconversion

LYNCHBURG, Va. --(BUSINESS WIRE)--Oct. 2, 2024-- BWX Technologies, Inc. (NYSE: BWXT) will issue a press release detailing third quarter 2024 results on Monday, November 4, 2024 , after market close and will host a conference call at 5:00 p.m. EST . Listen-only participants are encouraged to

$100,000 Contribution Underscores Community Commitment LYNCHBURG, Va. --(BUSINESS WIRE)--Oct. 2, 2024-- BWX Technologies, Inc. , the parent company of Nuclear Fuel Services (NFS), today announced a $100,000 donation to the Unicoi County United Way to support the recovery efforts underway in the

LYNCHBURG, Va. --(BUSINESS WIRE)--Aug. 26, 2024-- BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from the National Nuclear Security Administration (NNSA) to complete a yearlong engineering study to evaluate options for the deployment of a centrifuge pilot plant that would establish

KANATA, Ontario--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) has appointed Vittorio Puppo as president of BWXT Medical Ltd., effective August 12, 2024. In his new role, Puppo will focus on advancing the business’ mission to deliver high-quality nuclear medical products and solutions that

2Q24 revenues of $681.5 million 2Q24 net income of $73.0 million, adjusted EBITDA  (1)  of $126.2 million 2Q24 diluted GAAP EPS of $0.79, non-GAAP  (1)  EPS of $0.82 BWXT-led JV awarded management and operations contract for the NNSA’s Pantex Plant 2024 non-GAAP EPS  (1)  guidance revised to

Multi-year supply agreement for radium-226 processing and purification Collaboration will work to provide Ac-225 for clinical trials and commercial supply OTTAWA, Ontario & BELOIT, Wis.--(BUSINESS WIRE)-- BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc.

LYNCHBURG, Va.--(BUSINESS WIRE)-- BWX Technologies, Inc. (NYSE: BWXT) will issue a press release detailing second quarter 2024 results on Monday, August 5, 2024, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the